Novel Cost-Efficient Graphene-Based Impedance Biosensor for the Analysis of Viral Cytopathogenicity and the Effect of Antiviral Drugs

Biosensors become increasingly relevant for medical diagnostics, pharmaceutical industry, and environmental technology, for example, to test new drugs easily and reliably or to detect cell growth in changing environmental conditions. Novel materials like graphene are promising candidates to produce...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in bioengineering and biotechnology 2021-07, Vol.9, p.718889-718889
Main Authors: Schultz, Anke, Knoll, Thorsten, Urban, Andreas, Schuck, Herbert, von Briesen, Hagen, Germann, Anja, Velten, Thomas
Format: Article
Language:English
Subjects:
antiviral drugs
Bioengineering and Biotechnology
graphene ink
gravure printing
impedance biosensor
viral cytopathogenicity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Biosensors become increasingly relevant for medical diagnostics, pharmaceutical industry, and environmental technology, for example, to test new drugs easily and reliably or to detect cell growth in changing environmental conditions. Novel materials like graphene are promising candidates to produce biosensors on an industrial scale by means of printing processes. To reach this aim, methods for the reliable and automated production of electrode structures and their coating are required. We present an impedance biosensor in the format of a microtiter plate, fabricated by highly efficient roll-to-roll printing of graphene-based microstructures on large-area polymer foils. Proof-of-principle experiments show the evidence of the suitability of the printed graphene biosensors for impedance-based monitoring of viral cytopathogenicity and its inhibition in the presence of antiviral drugs. The developed system is a promising approach toward cost-efficient impedimetric biosensors for high-throughput screening in vaccine research and antiviral drug development.
ISSN:2296-4185
2296-4185
DOI:10.3389/fbioe.2021.718889